Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer.
Saved in:
| Title: | Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer. |
|---|---|
| Authors: | Hoppe MM; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Jaynes P; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Wardyn JD; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Upadhyayula SS; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Tan TZ; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Lie S; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Lim DGZ; Department of Pathology, National University Hospital, Singapore., Pang BNK; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; Department of Pathology, National University Hospital, Singapore., Lim S; Cancer Science Institute of Singapore, National University of Singapore, Singapore., P S Yeong J; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Karnezis A; British Columbia Cancer Agency, Vancouver, BC, Canada., Chiu DS; British Columbia Cancer Agency, Vancouver, BC, Canada., Leung S; British Columbia Cancer Agency, Vancouver, BC, Canada., Huntsman DG; British Columbia Cancer Agency, Vancouver, BC, Canada., Sedukhina AS; Department of Pharmacogenomics, St. Marianna University, Kawasaki, Japan., Sato K; Department of Pharmacogenomics, St. Marianna University, Kawasaki, Japan., Topp MD; The Walter and Eliza Hall Institute of Medical Research, Parkville, Vic., Australia., Scott CL; The Walter and Eliza Hall Institute of Medical Research, Parkville, Vic., Australia., Choi H; Saw Swee Hock School of Public Health, National University of Singapore, Singapore., Patel NR; Division of Cancer, Imperial College London, London, UK., Brown R; Division of Cancer, Imperial College London, London, UK., Kaye SB; Department of Haematology-Oncology, National University Hospital, Singapore., Pitt JJ; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Tan DSP; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; Department of Haematology-Oncology, National University Hospital, Singapore., Jeyasekharan AD; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; Department of Haematology-Oncology, National University Hospital, Singapore. |
| Source: | EMBO molecular medicine [EMBO Mol Med] 2021 May 07; Vol. 13 (5), pp. e13366. Date of Electronic Publication: 2021 Mar 11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
